Evaluation of commercially available immuno-magnetic agglutination in comparison to enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19.
Maria E MoellerJeppe FockPearlyn PahAntia De La C VerasMelanie BadeMarco DonolatoSimone Bastrup IsraelsenJesper Eugen-OlsenThomas Lars BenfieldFrederik N EngsigPublished in: Journal of medical virology (2021)
IMA for COVID-19 is a rapid simple-to-use point-of-care test with sensitivity and specificity similar to a commercial ELISA.